Article Versions Notes

Elledge C, Zhang Y, Shin S-U, Cho H-M, Ramakrishnan S, Sankar A, Chapman JR, Bilbao D, Das R, Gil-Henn H, et al. Modeling Lymphoma Angiogenesis, Lymphangiogenesis, and Vessel Co-Option, and the Effects of Inhibition of Lymphoma–Vessel Interactions with an αCD20-EndoP125A Antibody Fusion Protein. Cells. 2024; 13(22):1835. https://doi.org/10.3390/cells13221835

Elledge, Christian, Yu Zhang, Seung-Uon Shin, Hyun-Mi Cho, Sundaram Ramakrishnan, Ankita Sankar, Jennifer R. Chapman, Daniel Bilbao, Rathin Das, Hava Gil-Henn, and et al. 2024. "Modeling Lymphoma Angiogenesis, Lymphangiogenesis, and Vessel Co-Option, and the Effects of Inhibition of Lymphoma–Vessel Interactions with an αCD20-EndoP125A Antibody Fusion Protein" Cells 13, no. 22: 1835. https://doi.org/10.3390/cells13221835

Elledge, C., Zhang, Y., Shin, S.-U., Cho, H.-M., Ramakrishnan, S., Sankar, A., Chapman, J. R., Bilbao, D., Das, R., Gil-Henn, H., Lossos, I. S., & Rosenblatt, J. D. (2024). Modeling Lymphoma Angiogenesis, Lymphangiogenesis, and Vessel Co-Option, and the Effects of Inhibition of Lymphoma–Vessel Interactions with an αCD20-EndoP125A Antibody Fusion Protein. Cells, 13(22), 1835. https://doi.org/10.3390/cells13221835